Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Reproducibility and Method Comparison Studies of the Quo-Test™ A1C System and the Quo-Lab A1C Test and CLIA Waiver Study of the Quo-Test™ A1C System

This study has been terminated.
(Data for Study Devices vs. Predicate not within allowable ranges.)
Sponsor:
Information provided by (Responsible Party):
Quotient Diagnostics Limited
ClinicalTrials.gov Identifier:
NCT01829061
First received: April 1, 2013
Last updated: March 28, 2016
Last verified: November 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2014
  Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)